AlphaMaven AlphaMaven

Private Equity to Buy Bodycote, Gamma in Latest London Takeovers

Reported by Bloomberg
Sep 1, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Apollo Global Management made a £1.5 billion (approximately $2.0–$2.04 billion) conditional cash proposal to acquire Bodycote, a London-listed heat treatment and components specialist, but subsequently withdrew the bid without proceeding to a formal offer.
  • • Under UK takeover rules, Apollo had until June 19 to announce a firm intention to make an offer; the firm chose not to advance the proposal, ending discussions with Bodycote.
  • • The withdrawal of Apollo's bid caused Bodycote shares to plunge more than 10% in early London trading, nearly erasing the 18.4% share price gain that had occurred following the initial takeover approach announcement.
  • • Bodycote, identified as the world's largest heat treater, was the target of what would have represented a significant private equity acquisition of a major FTSE 250-listed industrial services company.
Summary
Apollo Global Management approached Bodycote, a London-listed heat treatment and industrial components specialist and the world's largest heat treater, with a conditional cash proposal valuing the company at £1.5 billion (approximately $2.0–$2.04 billion). The proposal marked a notable private equity interest in the FTSE 250-listed group, a sector that has attracted increasing takeover attention from alternative asset managers in recent years.

Under UK takeover regulations, Apollo was granted until June 19 to either announce a firm intention to make a formal offer or withdraw from consideration. The initial disclosure of the approach drove Bodycote shares up 18.4% as market participants anticipated a potential transaction. However, Apollo ultimately declined to proceed, announcing that it did not intend to make a firm takeover offer and ending discussions with Bodycote.

The withdrawal proved immediately damaging to shareholder value. Bodycote shares fell more than 10% in early trading following the announcement, nearly reversing the gains accumulated since Apollo's initial proposal had been disclosed. The rapid reversal underscores the market's sensitivity to deal terminations in the private equity space and the valuation risk investors face when acquisition proposals collapse at critical decision points.

The failed pursuit reflects the inherent uncertainty in large private equity transactions, particularly at valuations that may not withstand deeper financial diligence or when deal structures prove difficult to execute. For institutional investors holding Bodycote, the episode represented a material near-term loss of optionality and a reset of expectations regarding strategic alternatives for the business.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Bloomberg Private Equity to Buy Bodycote, Gamma in Latest London Takeovers